Simplex Trading, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.63 - $21.74 $89,013 - $109,765	5,049 New	5,049 $99,000
Q1 2023 Apr 27, 2023	BUY	$10.7 - $15.79 $481 - $710	45 Added 12.86%	395 $4,000
Q4 2022 Feb 02, 2023	BUY	$11.42 - $17.05 $3,997 - $5,967	350 New	350 $5,000
Q1 2022 May 02, 2022	SELL	$9.3 - $12.37 $28,383 - $37,753	-3,052 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$10.39 - $15.15 $198,874 - $289,986	-19,141 Reduced 86.25%	3,052 $35,000
Q3 2021 Oct 28, 2021	BUY	$11.39 - $16.23 $1,139 - $1,623	100 Added 0.45%	22,193 $321,000
Q2 2021 Aug 12, 2021	BUY	$13.22 - $19.09 $209,113 - $301,965	15,818 Added 252.08%	22,093 $307,000
Q1 2021 Apr 26, 2021	BUY	$16.68 - $23.97 $104,667 - $150,411	6,275 New	6,275 $116,000
Q4 2020 Feb 02, 2021	SELL	$14.8 - $21.15 $17,256 - $24,660	-1,166 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$15.21 - $25.53 $10,707 - $17,973	704 Added 152.38%	1,166 $17,000
Q2 2020 Jul 13, 2020	BUY	$15.08 - $26.0 $6,966 - $12,012	462 New	462 $11,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.